SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CorMedix Therapeutics to participate in Wells Fargo Healthcare Conference

CorMedix Therapeutics said senior management will participate in a fireside at the Wells Fargo Healthcare Conference.

CRMD
SquawkNews Desk

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories

Nscale Banking Partners Commit Further $2.09 Billion for 300MW Projects The conditional commitment funds development of additional data center projects at SIN02 in Portugal and Norway. M impact | EQUITY | Nov 12, 2026, 10:33 PM UTC WELL Health Reports Q3 Revenue Growth, Reaffirms EBITDA Guidance WELL Health reported revenue of $407.4 million, up 12% year over year, and adjusted EBITDA of $50.9 million, above consensus. It reaffirmed fiscal 2026 adjusted EBITDA guidance of M impact | EQUITY | Nov 12, 2026, 10:33 PM UTC Tidewater Midstream Raises 2026 EBITDA Guidance After Q3 Results Tidewater reported record third-quarter adjusted EBITDA of $96.9 million and raised its 2026 guidance to $300 million–$320 million from $230 million–$250 million. It lowered its ca M impact | EQUITY | Nov 12, 2026, 10:33 PM UTC NeuroPace Cuts 2026 Revenue Guidance as Q3 Revenue Declines NeuroPace reported a narrower net loss for the third quarter of 2026, while total revenue declined. Management reduced its full-year 2026 revenue guidance. M impact | EQUITY | Nov 12, 2026, 10:33 PM UTC VICI Properties Closes $500 Million Term Loan to Refinance 2027 Notes VICI Properties said a subsidiary closed a $500 million term loan to refinance 2027 notes. M impact | EQUITY | Nov 12, 2026, 10:32 PM UTC Flowers Foods Cuts Full-Year Outlook After Third-Quarter Results Flowers Foods said consumer spending weakness and increased promotional activity weighed on third-quarter results. It reported profit of $14.4 million, or 7 cents a share; the outl M impact | EQUITY | Nov 12, 2026, 10:31 PM UTC